Abstract
Pediatric Blood & CancerVolume 60, Issue 9 p. 1559-1560 Letter To The Editor Novel frameshift mutations in ADAMTS13 in two families with hereditary thrombotic thrombocytopenic purpura Abdulrahman Alsultan, Corresponding Author Abdulrahman Alsultan Department of Oncology, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia Correspondence to: Abdulrahman Alsultan, MD, Department of Pediatrics, College of Medicine, King Saud University, PO Box 261691, Riyadh 11342, Saudi Arabia. E-mail: aalsultan1@ksu.edu.saSearch for more papers by this authorMohammed Jarrar, Mohammed Jarrar Department of Oncology, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi ArabiaSearch for more papers by this authorTalal Al-Harbi, Talal Al-Harbi Department of Oncology, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi ArabiaSearch for more papers by this authorMohammed AL Balwi, Mohammed AL Balwi Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia King Abdullah International Medical Research Center, Riyadh, Saudi Arabia College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi ArabiaSearch for more papers by this author Abdulrahman Alsultan, Corresponding Author Abdulrahman Alsultan Department of Oncology, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia Correspondence to: Abdulrahman Alsultan, MD, Department of Pediatrics, College of Medicine, King Saud University, PO Box 261691, Riyadh 11342, Saudi Arabia. E-mail: aalsultan1@ksu.edu.saSearch for more papers by this authorMohammed Jarrar, Mohammed Jarrar Department of Oncology, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi ArabiaSearch for more papers by this authorTalal Al-Harbi, Talal Al-Harbi Department of Oncology, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi ArabiaSearch for more papers by this authorMohammed AL Balwi, Mohammed AL Balwi Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia King Abdullah International Medical Research Center, Riyadh, Saudi Arabia College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi ArabiaSearch for more papers by this author First published: 16 May 2013 https://doi.org/10.1002/pbc.24594Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume60, Issue9September 2013Pages 1559-1560 RelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
